Skip to main content
Products
New Products
Commercial
Under Development
Under Evaluation
Advanced Intermediates
Services
News & Events
About
Our Team
Environmnetal Responsibility
History
Global Presence
Facilities
Quality Commitment
Customer Service
Knowledge Center
Careers
Hebrew Career
Contact Us
News
Home
»
News & Events
»
News
SK Capital Partners completes acquisition of SEQENS and merges Wavelength Pharmaceuticals to create an integrated global API CDMO leader
Read more
SK Capital Partners has completed the acquisition of a majority stake in SEQENS along with the merger of Wavelength Pharmaceuticals into SEQENS to create an integrated global API CDMO leader…
Wavelength will be exhibiting at CPhI Europe 2021
Read more
CPhI EU has been postponed to November 9 – 11, 2021. Visit us at CPhI Europe to find out more about our latest products, custom development & manufacturing services. Contact us today to schedule a meeting! Wavelength Pharmaceuticals is…
SK Capital Partners to acquire SEQENS and merge Wavelength Pharmaceuticals to create an integrated global API CDMO leader
Read more
SK Capital Partners has entered into exclusive discussions to acquire a majority stake in SEQENS – a leading integrated developer and manufacturer of Active Pharmaceutical Ingredients, advanced drug intermediates and specialty ingredients.
Wavelength Pharmaceuticals Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19 Patients
Read more
Long-Time Provider of High-Quality APIs Ramps Up Supply to Meet Surging Demand for Products Needed to Manage Respiratory Critical Care Patients. Company Also Announces CDMO Service Enabling Pharmaceutical Firms Access to Its API Development and Regulatory Expertise…
Wavelength Pharmaceuticals Further Strengthens Its Global Supply Chain with Acquisition of Vanamali Organics
Read more
Leading Developer and Manufacturer of APIs Acquires an Established Custom Research and Manufacturing Services Provider Focused on Pharmaceutical Key Starting Materials and Advanced Drug Intermediates.
Wavelength Pharmaceuticals signs collaboration agreement with Tikun olam-Cannbit for development, manufacturing and marketing of Pharma Grade cGMP cannabis-based active pharmaceutical ingredients (APIs)
Read more
Wavelength Pharmaceuticals signs collaboration agreement with Tikun olam-Cannbit for development, manufacturing and marketing of Pharma Grade cGMP cannabis-based active pharmaceutical ingredients (APIs).
Biocatalysis: An Indispensable Tool for API Synthesis
Read more
Enzymatic Chemistry is widely recognized to be one of the most powerful tools for organic synthesis due to its green credentials and its exquisite regio-, enantio-, and stereoselectivities…
Wavelength will be exhibiting at Biomed 2021
Read more
BIOMED has been postponed to May 11- May 13, 2021. Visit us at BIOMED to find out more about our latest products, custom development & manufacturing services. Wavelength Pharmaceuticals is a world class developer and manufacturer of high-quality APIs…
DCAT Week Virtual Event
Read more
Wavelength to participate in the DCAT Week Virtual Event, to find out more about our latest products, custom development & manufacturing services Contact us! July 12-16, 2021 Wavelength Pharmaceuticals is a world class developer and manufacturer of high-quality APIs and…
Global Conference on Medical Cannabis and Cannabidiol
Read more
Wavelength will be exhibiting at the GLOBAL VIRTUAL CONFERENCE ON MEDICAL CANNABIS AND CANNABIDIOL 2021 June 3rd and 4th
Wavelength will be exhibiting at CPhI North America 2021
Read more
CPhI North America has been postponed to August 10 – August 12, 2021. Visit us at CPhI North America to find out more about our latest products, custom development & manufacturing services. Contact us today to schedule a meeting! Wavelength…
Wavelength will be exhibiting at Contract Pharma’s 2021 Contracting & Outsourcing Conference
Read more
Visit us at Contract Pharma’s 2021 Contracting & Outsourcing Conference to find out more about our latest products, custom development & manufacturing services. Contact us today to schedule a meeting! Wavelength Pharmaceuticals is a world class developer and manufacturer…
Wavelength to participate in the 29th Online CMC Virtual Strategy Meeting 2020
Read more
Please visit the link for more information
Wavelength to participate in the CPhIdiscover Online Event
Read more
Wavelength to participate in the CPhIdiscover Online Event, to find out more about our latest products, custom development & manufacturing services Contact us!
Show more...